In silico validation of the Autoinflammatory ...
Type de document :
Article dans une revue scientifique
PMID :
URL permanente :
Titre :
In silico validation of the Autoinflammatory Disease Damage Index.
Auteur(s) :
Ter Haar Nienke, M [Auteur]
Van Delft Amber Laetitia, Justine [Auteur]
Annink Kim, Valerie [Auteur]
Van Stel, Henk [Auteur]
Al-Mayouf Sulaiman, M [Auteur]
Amaryan, Gayane [Auteur]
Anton, Jordi [Auteur]
Barron Karyl, S [Auteur]
Benseler, Susanne [Auteur]
Brogan Paul, A [Auteur]
Cantarini, Luca [Auteur]
Cattalini, Marco [Auteur]
Cochino, Alexis-Virgil [Auteur]
De Benedetti, Fabrizio [Auteur]
Dedeoglu, Fatma [Auteur]
De Jesus Adriana, Almeida [Auteur]
Demirkaya, Erkan [Auteur]
Dolezalova, Pavla [Auteur]
Durrant Karen, L [Auteur]
Fabio, Giovanna [Auteur]
Gallizzi, Romina [Auteur]
Goldbach-Mansky, Raphaela [Auteur]
Hachulla, Eric [Auteur]
Lille Inflammation Research International Center - U 995 [LIRIC]
Hentgen, Veronique [Auteur]
Herlin, Troels [Auteur]
Hofer, Michael [Auteur]
Hoffman Hal, M [Auteur]
Insalaco, Antonella [Auteur]
Jansson Annette, F [Auteur]
Kallinich, Tilmann [Auteur]
Kone-Paut, Isabelle [Auteur]
Université Paris-Sud - Paris 11 [UP11]
Kozlova, Anna [Auteur]
Kuemmerle-Deschner Jasmin, Beate [Auteur]
Lachmann Helen, J [Auteur]
Laxer Ronald, M [Auteur]
Martini, Alberto [Auteur]
Nielsen, Susan [Auteur]
Nikishina, Irina [Auteur]
Ombrello Amanda, K [Auteur]
Ozen, Seza [Auteur]
Papadopoulou-Alataki, Efimia [Auteur]
Quartier, Pierre [Auteur]
Imagine - Institut des maladies génétiques [IMAGINE - U1163]
Université Paris Descartes - Paris 5 [UPD5]
Rigante, Donato [Auteur]
Russo, Ricardo [Auteur]
Simon, Anna [Auteur]
Trachana, Maria [Auteur]
Uziel, Yosef [Auteur]
Ravelli, Angelo [Auteur]
Schulert, Grant [Auteur]
Gattorno, Marco [Auteur]
Frenkel, Joost [Auteur]
Van Delft Amber Laetitia, Justine [Auteur]
Annink Kim, Valerie [Auteur]
Van Stel, Henk [Auteur]
Al-Mayouf Sulaiman, M [Auteur]
Amaryan, Gayane [Auteur]
Anton, Jordi [Auteur]
Barron Karyl, S [Auteur]
Benseler, Susanne [Auteur]
Brogan Paul, A [Auteur]
Cantarini, Luca [Auteur]
Cattalini, Marco [Auteur]
Cochino, Alexis-Virgil [Auteur]
De Benedetti, Fabrizio [Auteur]
Dedeoglu, Fatma [Auteur]
De Jesus Adriana, Almeida [Auteur]
Demirkaya, Erkan [Auteur]
Dolezalova, Pavla [Auteur]
Durrant Karen, L [Auteur]
Fabio, Giovanna [Auteur]
Gallizzi, Romina [Auteur]
Goldbach-Mansky, Raphaela [Auteur]
Hachulla, Eric [Auteur]
Lille Inflammation Research International Center - U 995 [LIRIC]
Hentgen, Veronique [Auteur]
Herlin, Troels [Auteur]
Hofer, Michael [Auteur]
Hoffman Hal, M [Auteur]
Insalaco, Antonella [Auteur]
Jansson Annette, F [Auteur]
Kallinich, Tilmann [Auteur]
Kone-Paut, Isabelle [Auteur]
Université Paris-Sud - Paris 11 [UP11]
Kozlova, Anna [Auteur]
Kuemmerle-Deschner Jasmin, Beate [Auteur]
Lachmann Helen, J [Auteur]
Laxer Ronald, M [Auteur]
Martini, Alberto [Auteur]
Nielsen, Susan [Auteur]
Nikishina, Irina [Auteur]
Ombrello Amanda, K [Auteur]
Ozen, Seza [Auteur]
Papadopoulou-Alataki, Efimia [Auteur]
Quartier, Pierre [Auteur]
Imagine - Institut des maladies génétiques [IMAGINE - U1163]
Université Paris Descartes - Paris 5 [UPD5]
Rigante, Donato [Auteur]
Russo, Ricardo [Auteur]
Simon, Anna [Auteur]
Trachana, Maria [Auteur]
Uziel, Yosef [Auteur]
Ravelli, Angelo [Auteur]
Schulert, Grant [Auteur]
Gattorno, Marco [Auteur]
Frenkel, Joost [Auteur]
Titre de la revue :
Annals of the Rheumatic Diseases
Nom court de la revue :
Ann. Rheum. Dis.
Numéro :
77
Pagination :
1599-1605
Date de publication :
2018-10-11
ISSN :
1468-2060
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
INTRODUCTION: Autoinflammatory diseases can cause irreversible tissue damage due to systemic inflammation. Recently, the Autoinflammatory Disease Damage Index (ADDI) was developed. The ADDI is the first instrument to ...
Lire la suite >INTRODUCTION: Autoinflammatory diseases can cause irreversible tissue damage due to systemic inflammation. Recently, the Autoinflammatory Disease Damage Index (ADDI) was developed. The ADDI is the first instrument to quantify damage in familial Mediterranean fever, cryopyrin-associated periodic syndromes, mevalonate kinase deficiency and tumour necrosis factor receptor-associated periodic syndrome. The aim of this study was to validate this tool for its intended use in a clinical/research setting. METHODS: The ADDI was scored on paper clinical cases by at least three physicians per case, independently of each other. Face and content validity were assessed by requesting comments on the ADDI. Reliability was tested by calculating the intraclass correlation coefficient (ICC) using an 'observer-nested-within-subject' design. Construct validity was determined by correlating the ADDI score to the Physician Global Assessment (PGA) of damage and disease activity. Redundancy of individual items was determined with Cronbach's alpha. RESULTS: The ADDI was validated on a total of 110 paper clinical cases by 37 experts in autoinflammatory diseases. This yielded an ICC of 0.84 (95% CI 0.78 to 0.89). The ADDI score correlated strongly with PGA-damage (r=0.92, 95% CI 0.88 to 0.95) and was not strongly influenced by disease activity (r=0.395, 95% CI 0.21 to 0.55). After comments from disease experts, some item definitions were refined. The interitem correlation in all different categories was lower than 0.7, indicating that there was no redundancy between individual damage items. CONCLUSION: The ADDI is a reliable and valid instrument to quantify damage in individual patients and can be used to compare disease outcomes in clinical studies.Lire moins >
Lire la suite >INTRODUCTION: Autoinflammatory diseases can cause irreversible tissue damage due to systemic inflammation. Recently, the Autoinflammatory Disease Damage Index (ADDI) was developed. The ADDI is the first instrument to quantify damage in familial Mediterranean fever, cryopyrin-associated periodic syndromes, mevalonate kinase deficiency and tumour necrosis factor receptor-associated periodic syndrome. The aim of this study was to validate this tool for its intended use in a clinical/research setting. METHODS: The ADDI was scored on paper clinical cases by at least three physicians per case, independently of each other. Face and content validity were assessed by requesting comments on the ADDI. Reliability was tested by calculating the intraclass correlation coefficient (ICC) using an 'observer-nested-within-subject' design. Construct validity was determined by correlating the ADDI score to the Physician Global Assessment (PGA) of damage and disease activity. Redundancy of individual items was determined with Cronbach's alpha. RESULTS: The ADDI was validated on a total of 110 paper clinical cases by 37 experts in autoinflammatory diseases. This yielded an ICC of 0.84 (95% CI 0.78 to 0.89). The ADDI score correlated strongly with PGA-damage (r=0.92, 95% CI 0.88 to 0.95) and was not strongly influenced by disease activity (r=0.395, 95% CI 0.21 to 0.55). After comments from disease experts, some item definitions were refined. The interitem correlation in all different categories was lower than 0.7, indicating that there was no redundancy between individual damage items. CONCLUSION: The ADDI is a reliable and valid instrument to quantify damage in individual patients and can be used to compare disease outcomes in clinical studies.Lire moins >
Langue :
Anglais
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
Inserm
Université de Lille
CHU Lille
Université de Lille
CHU Lille
Équipe(s) de recherche :
Immunity, inflammation and fibrsis in auto and allo-reactivity
Date de dépôt :
2019-03-01T14:17:43Z
2024-01-25T13:34:11Z
2024-01-25T13:34:11Z